Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus
Eli Lilly has signed a definitive agreement with Nexus Pharmaceuticals wherein Lilly will be acquiring a manufacturing facility from Nexus.
Eli Lilly | 23/04/2024 | By Aishwarya | 202
Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility
Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility
Eli Lilly | 13/07/2023 | By Sudeep Soparkar | 428
Eli Lilly promises additional $1.6 bn manufacturing investment
200 new jobs are planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US
Eli Lilly | 19/04/2023 | By Sudeep Soparkar | 276
Eli Lilly plans $450 M expansion plans
The company will increase the headcount by 100 more employees.
Eli Lilly | 25/01/2023 | By Sudeep Soparkar | 435
US FDA approval for Incyte's Olumiant
Eli Lilly and Company and Incyte announced the US Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for the treatment of Covid-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) with a recommended dose of 4-mg once daily for 14 days.
Eli Lilly | 12/05/2022 | By Sudeep Soparkar | 444
Kyttaro and Lily come together to get license deal
UK-based startup Kyttaro and Eli Lilly have announced a new licensing deal.
Eli Lilly | 14/04/2022 | By Sudeep Soparkar | 516
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy